Z-100 + Placebo
Phase 3Completed 0 watching 0 views this weekπ Rising
76
Development Stage
β
Pre-clinicalβ
Phase 1β
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Cancer
Conditions
Cervical Cancer
Trial Timeline
Dec 1, 2014 β Feb 25, 2022
NCT ID
NCT02247232About Z-100 + Placebo
Z-100 + Placebo is a phase 3 stage product being developed by Zeria Pharmaceutical for Cervical Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT02247232. Target conditions include Cervical Cancer.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02247232 | Phase 3 | Completed |
Competing Products
20 competing products in Cervical Cancer